Embecta (EMBC) Research & Development (2020 - 2026)
Embecta's (EMBC) quarterly Research & Development came in at $5.4 million in Q1 2026, down 32.5% year-on-year from $8.0 million in Q1 2025, and up 17.39% quarter-over-quarter from $4.6 million in Q4 2025.
Embecta (EMBC) Research & Development (2020 - 2026) Analysis & Trends
Embecta has disclosed Research & Development across 7 years of filings, most recently posting $5.4 million for Q1 2026.
- Research & Development for Q1 2026 came in at $5.4 million, down 32.5% year-over-year; the trailing twelve-month figure through Mar 2026 was $19.0 million (down 72.26% YoY), and the FY2025 annual result was $37.3 million, down 52.66% from the prior year.
- Research & Development came in at $5.4 million for Q1 2026 at Embecta, up from $4.6 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of $23.6 million in Q3 2023 to a low of $4.4 million in Q2 2025.
- The 5-year median for Research & Development is $18.0 million (2022), against an average of $15.4 million.
- Across the five-year window, Research & Development jumped 58.04% in 2023 and tumbled 78.43% in 2025, its largest moves.
- Embecta's Research & Development stood at $16.9 million in 2022, then advanced by 19.53% to $20.2 million in 2023, then increased by 0.5% to $20.3 million in 2024, then slumped by 77.34% to $4.6 million in 2025, then increased by 17.39% to $5.4 million in 2026.
- The last three Research & Development figures came in at $5.4 million (Q1 2026), $4.6 million (Q4 2025), and $4.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 361.90 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 249.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | - |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 94.27 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 15.80 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 189.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 42.50 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 98.66 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 139.00 Mn |
| 10 | Embecta | 183.23 Mn | -10.17 Mn | 127.80 Mn | 5.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.40 Mn |
| Dec 31, 2025 | 4.60 Mn |
| Sep 30, 2025 | 4.60 Mn |
| Jun 30, 2025 | 4.40 Mn |
| Mar 31, 2025 | 8.00 Mn |
| Dec 31, 2024 | 20.30 Mn |
| Sep 30, 2024 | 19.80 Mn |
| Jun 30, 2024 | 20.40 Mn |
| Mar 31, 2024 | 18.40 Mn |
| Dec 31, 2023 | 20.20 Mn |
| Sep 30, 2023 | 23.60 Mn |
| Jun 30, 2023 | 22.60 Mn |
| Mar 31, 2023 | 22.10 Mn |
| Dec 31, 2022 | 16.90 Mn |
| Sep 30, 2022 | 17.90 Mn |
| Jun 30, 2022 | 14.30 Mn |
| Mar 31, 2022 | 18.00 Mn |
| Dec 31, 2021 | 16.70 Mn |
| Sep 30, 2021 | 19.50 Mn |
| Jun 30, 2021 | 15.70 Mn |